(S)-4-(tert-Butyl)-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 250mg

METHYL 2-CHLORO-3-NITROISONICOTINATE, 95.0%, 100mg

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 100mg

3,5-Dibenzyloxybenzaldehyde>98.0%(GC)1g

5-BROMO-3-(1-METHYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE, 97.0%, 5g

5-Bromo-8-chloro-1,7-naphthyridine, 90.0%, 1g

5-(2-Thioxo-2,3-dihydrothiazol-4-yl)thiophene-2-carboxamide, 95.0%, 25mg

(1S,2R)-2-METHOXYCARBONYL-CYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 1g

1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

1-(2,3,4,5-Tetrafluorophenyl)ethanone, 95.0%, 1g

Protein G Recombinant, expressed in Escherichia coli1vial

3,3-Diethoxybutan-2-one, 95%, 100mg

2-BROMO-3,5-BIS(TRIFLUOROMETHYL)ANISOLE, 95.0%, 5g